sobuzoxane has been researched along with Mycosis Fungoides in 1 studies
sobuzoxane: used in treatment of leukemia L1210
Mycosis Fungoides: A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, Y | 1 |
| Fukuhara, Y | 1 |
| Nagatani, T | 1 |
| Kanzaki, A | 1 |
| Mae, KI | 1 |
| Irisawa, R | 1 |
| Harada, K | 1 |
| Umebayashi, Y | 1 |
| Tsuboi, R | 1 |
1 other study available for sobuzoxane and Mycosis Fungoides
| Article | Year |
|---|---|
Low-Dose MST-16/VP-16 Combination Chemotherapy in 9 Patients with Tumor Stage Mycosis Fungoides.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle A | 2022 |